Citation

90 FR 15253

Multiple canonical documents share this first-page citation.

Teva Pharmaceuticals USA, Inc., et al.; Withdrawal of Approval of 23 Abbreviated New Drug Applications; Correction Wednesday, April 9, 2025 90 FR 15253
Determination That VIBRAMYCIN (Doxycycline) for Oral Suspension, Equivalent 25 Milligrams Base/5 Milliliter, Was Not Withdrawn From Sale for Reasons of Safety or Effectiveness Wednesday, April 9, 2025 90 FR 15253